All stock lists
Unlock the score
Astrazeneca PLC (NYSE:AZN)
United Kingdom · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - General
171.09-0.40 (-0.23%)
Insider Score
/ 100
AZN Insider Score
ASTRAZENECA PLC has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
AZN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 15.38 B | 15.29 B | 15.50 B | 15.19 B | 14.46 B | — |
| Revenue Growth (YoY) | 6.41 % | — | — | — | — | — |
| Cost of Revenue | 2.52 B | 2.68 B | 3.12 B | 2.80 B | 2.47 B | — |
| Gross Profit | 12.86 B | 12.61 B | 12.38 B | 12.39 B | 11.98 B | — |
| SG&A Expense | 5.80 B | 5.06 B | 5.64 B | 5.23 B | 5.01 B | — |
| R&D Expense | 4.05 B | 3.49 B | 3.86 B | 3.66 B | 3.55 B | — |
| Operating Expenses | 9.70 B | 8.36 B | 9.41 B | 8.81 B | 8.48 B | — |
| Operating Income | 3.16 B | 4.25 B | 2.98 B | 3.58 B | 3.51 B | — |
| Pretax Income | 2.80 B | 3.91 B | 2.63 B | 3.24 B | 3.13 B | — |
| Tax Provision | 291.00 M | 833.00 M | 300.00 M | 709.00 M | 679.00 M | — |
| Net Income | 2.51 B | 3.08 B | 2.33 B | 2.53 B | 2.45 B | — |
| EPS (Basic) | 1.61 | 1.99 | 1.50 | — | 1.58 | 1.88 |
| EPS (Diluted) | 1.61 | 1.97 | 1.49 | — | 1.57 | 1.87 |
| Shares Outstanding | 1.55 B | 1.55 B | 1.55 B | — | 1.55 B | 1.55 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.